AG真人官方

Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- (Nasdaq: AMLX) (鈥淎mylyx鈥� or the 鈥淐ompany鈥�) will report its second quarter 2025 financial results on Thursday, August 7, 2025. Amylyx鈥� senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.

To access the conference call, please dial +1 (800) 836-8184 (U.S. & Canada) or +1 (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to be joined into the Amylyx Pharmaceuticals call. A live audio webcast of the call will be available under 鈥淓vents and Presentations鈥� in the Investor section of the Company鈥檚 website, . The webcast will be archived and available for replay for 90 days following the event.

About Amylyx Pharmaceuticals

At Amylyx, our mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are currently focused on three investigational therapies across several neurodegenerative and endocrine diseases in which we believe they can make the greatest impact. For more information, visit and follow us on and . For investors, please visit .

View source version on businesswire.com:

Media

Amylyx Media Team

+1 (857) 320-6244

[email protected]



Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

+1 (857) 320-6244

[email protected]

Source: Amylyx Pharmaceuticals, Inc.